UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Neuroactive Steroids. 2. 3α-Hydroxy-3β-methyl-21-(4-cyano‑1H‑pyrazol-1′-yl)-19-nor-5β-pregnan-20-one (SAGE-217): A Clinical Next Generation Neuroactive Steroid Positive Allosteric Modulator of the (γ-Aminobutyric Acid)A Receptor

Journal of medicinal chemistry, 2017-09, Vol.60 (18), p.7810-7819

2017

Volltextzugriff (PDF)

SAGE-217, A Novel GABA A Receptor Positive Allosteric Modulator: Clinical Pharmacology and Tolerability in Randomized Phase I Dose-Finding Studies

Clinical pharmacokinetics, 2020-01, Vol.59 (1), p.111

2020

Volltextzugriff (PDF)

Photosensitive epilepsy: Robust clinical efficacy of a selective GABA potentiator

Neurology, 2019-04, Vol.92 (15), p.e1786

2019

Volltextzugriff (PDF)

Enhancement of GABAergic activity: neuropharmacological effects of benzodiazepines and therapeutic use in anesthesiology

Pharmacological reviews, 2011-03, Vol.63 (1), p.243-267

2011

Volltextzugriff (PDF)

The Clinical and Forensic Toxicology of Z-drugs

Journal of medical toxicology, 2013-06, Vol.9 (2), p.155-162

Gunja, Naren

2013

Volltextzugriff (PDF)

Modeling the Effect of Excitation on Depth of Anesthesia Monitoring in γ-Aminobutyric Acid Type A Receptor Agonist ABP-700

Anesthesiology (Philadelphia), 2021-01, Vol.134 (1), p.35-51

2021

Volltextzugriff (PDF)

Application of in vitro data in physiologically-based kinetic models for quantitative in vitro-in vivo extrapolation: A case-study for baclofen

Toxicology in vitro, 2021-10, Vol.76, p.105223, Article 105223

2021

Volltextzugriff (PDF)

In the Zzz Zone: The Effects of Z-Drugs on Human Performance and Driving

Journal of medical toxicology, 2013-06, Vol.9 (2), p.163-171

Gunja, Naren

2013

Volltextzugriff (PDF)

Pharmacokinetics and exposure–safety relationship of ciprofol for sedation in mechanically ventilated patients in the intensive care unit

CPT: pharmacometrics and systems pharmacology, 2024-05, Vol.13 (5), p.823-836

2024

Volltextzugriff (PDF)

Pharmacokinetic characterization of baclofen in patients with chronic kidney disease: dose adjustment recommendations

Journal of clinical pharmacology, 2014-05, Vol.54 (5), p.584-592

2014

Volltextzugriff (PDF)

Synthesis, biological evaluation and molecular modeling study of some new thiazolodiazepine analogs as CNS active agents

Bioorganic & medicinal chemistry letters, 2016-01, Vol.26 (2), p.445-453

2016

Volltextzugriff (PDF)

Brain GABA levels are reduced in alcoholic liver disease: A proton magnetic resonance spectroscopy study

Addiction biology, 2020-01, Vol.25 (1), p.e12702-n/a

2020

Volltextzugriff (PDF)

Clinical Relevance of Pharmacological and Physiological Data in Intrathecal Baclofen Therapy

Archives of physical medicine and rehabilitation, 2014-11, Vol.95 (11), p.2199-2206

2014

Volltextzugriff (PDF)

Population pharmacokinetics of oral baclofen at steady‐state in alcoholic‐dependent adult patients

Fundamental & clinical pharmacology, 2018-04, Vol.32 (2), p.239-248

2018

Volltextzugriff (PDF)

Sh-I-048A, an in vitro non-selective super-agonist at the benzodiazepine site of GABAA receptors: The approximated activation of receptor subtypes may explain behavioral effects

Brain research, 2014-03, Vol.1554, p.36-48

2014

Volltextzugriff (PDF)

Zolpidem and zolpidem phenyl‐4‐carboxylic acid pharmacokinetics in oral fluid after a single dose

Drug testing and analysis, 2019-07, Vol.11 (7), p.1076-1082

2019

Volltextzugriff (PDF)

Dose-dependent effects of lesogaberan on reflux measures in patients with refractory gastroesophageal reflux disease: a randomized, placebo-controlled study

BMC gastroenterology, 2014-11, Vol.14 (1), p.188-188, Article 188

2014

Volltextzugriff (PDF)

Amorphous solid dispersion successfully improved oral exposure of ADX71943 in support of toxicology studies

Drug development and industrial pharmacy, 2013-09, Vol.39 (9), p.1300-1305

2013

Volltextzugriff (PDF)

Re-engineering a neuroprotective, clinical drug as a procognitive agent with high in vivo potency and with GABAA potentiating activity for use in dementia

BMC neuroscience, 2015-10, Vol.16 (1), p.67-67, Article 67

2015

Volltextzugriff (PDF)

Model-based meta-analysis of the effects of non-selective and α1-selective GABAA receptor agonists in healthy volunteers

European journal of clinical pharmacology, 2015-10, Vol.71 (10), p.1209-1221

2015

Volltextzugriff (PDF)

Remimazolam, a short-acting GABA(A) receptor agonist for intravenous sedation and/or anesthesia in day-case surgical and non-surgical procedures

IDrugs : the investigational drugs journal, 2010-12, Vol.13 (12), p.929

2010

Volltextzugriff (PDF)

The efficacy and biobehavioural basis of baclofen in the treatment of alcoholic liver disease (BacALD): Study protocol for a randomised controlled trial

Contemporary clinical trials, 2013-11, Vol.36 (2), p.348-355

2013

Volltextzugriff (PDF)

Pharmacokinetic Interaction Between Zolpidem and Carbamazepine in Healthy Volunteers

Journal of clinical pharmacology, 2011-08, Vol.51 (8), p.1233-1236

2011

Volltextzugriff (PDF)

Increased GABAA receptor binding in amygdala after prenatal administration of valproic acid to rats

Acta neuropsychiatrica, 2017-10, Vol.29 (5), p.309-314

2017

Volltextzugriff (PDF)

Zolpidem induces paradoxical metabolic and vascular changes in a patient with PVS

Brain injury, 2013-10, Vol.27 (11), p.1320-1329

2013

Volltextzugriff (PDF)

1 – 25 von 236

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(227)
Mit Volltextzugriff
(199)

Publikationsform

Artikel
(236)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Neuroactive Steroids. 2. 3α-Hydroxy-3β-methyl-21-(4-cyano‑1H‑pyrazol-1′-yl)-19-nor-5β-pregnan-20-one (SAGE-217): A Clinical Next Generation Neuroactive Steroid Positive Allosteric Modulator of the (γ-Aminobutyric Acid)A Receptor

SAGE-217, A Novel GABA A Receptor Positive Allosteric Modulator: Clinical Pharmacology and Tolerability in Randomized Phase I Dose-Finding Studies

Photosensitive epilepsy: Robust clinical efficacy of a selective GABA potentiator

Enhancement of GABAergic activity: neuropharmacological effects of benzodiazepines and therapeutic use in anesthesiology

The Clinical and Forensic Toxicology of Z-drugs

Modeling the Effect of Excitation on Depth of Anesthesia Monitoring in γ-Aminobutyric Acid Type A Receptor Agonist ABP-700

Application of in vitro data in physiologically-based kinetic models for quantitative in vitro-in vivo extrapolation: A case-study for baclofen

In the Zzz Zone: The Effects of Z-Drugs on Human Performance and Driving

Pharmacokinetics and exposure–safety relationship of ciprofol for sedation in mechanically ventilated patients in the intensive care unit

Pharmacokinetic characterization of baclofen in patients with chronic kidney disease: dose adjustment recommendations

Synthesis, biological evaluation and molecular modeling study of some new thiazolodiazepine analogs as CNS active agents

Brain GABA levels are reduced in alcoholic liver disease: A proton magnetic resonance spectroscopy study

Clinical Relevance of Pharmacological and Physiological Data in Intrathecal Baclofen Therapy

Population pharmacokinetics of oral baclofen at steady‐state in alcoholic‐dependent adult patients

Sh-I-048A, an in vitro non-selective super-agonist at the benzodiazepine site of GABAA receptors: The approximated activation of receptor subtypes may explain behavioral effects

Zolpidem and zolpidem phenyl‐4‐carboxylic acid pharmacokinetics in oral fluid after a single dose

Dose-dependent effects of lesogaberan on reflux measures in patients with refractory gastroesophageal reflux disease: a randomized, placebo-controlled study

Amorphous solid dispersion successfully improved oral exposure of ADX71943 in support of toxicology studies

Re-engineering a neuroprotective, clinical drug as a procognitive agent with high in vivo potency and with GABAA potentiating activity for use in dementia

Model-based meta-analysis of the effects of non-selective and α1-selective GABAA receptor agonists in healthy volunteers

Remimazolam, a short-acting GABA(A) receptor agonist for intravenous sedation and/or anesthesia in day-case surgical and non-surgical procedures

The efficacy and biobehavioural basis of baclofen in the treatment of alcoholic liver disease (BacALD): Study protocol for a randomised controlled trial

Pharmacokinetic Interaction Between Zolpidem and Carbamazepine in Healthy Volunteers

Increased GABAA receptor binding in amygdala after prenatal administration of valproic acid to rats

Zolpidem induces paradoxical metabolic and vascular changes in a patient with PVS

Suchergebnisse filtern